Bacterial persisters are phenotypic variants that survive antibiotic treatment in a dormant state and can be 2 formed by multiple pathways. We recently proposed that the second messenger (p)ppGpp drives Escherichia 3 coli persister formation through protease Lon and the activation of toxin-antitoxin (TA) modules. This model 4 found support in the field, but also generated controversy as part of recent heated debates on the validity of 5 significant parts of the literature. In this study, we therefore used our previous work as a model to critically 6 examine common experimental procedures in order to understand and overcome the inconsistencies often 7 observed between results of different laboratories. Our results show that seemingly simple antibiotic killing 8 assays are very sensitive to variation of culture conditions and bacterial growth phase. Additionally, we found 9 that some assay conditions cause the killing of antibiotic-tolerant persisters via induction of cryptic prophages. 10
formation of this strain in direct comparison to the parental wildtype and the Δ10TA mutants ( Figure 5D ). 13
When the experiment was performed as a single growth time-point assay in LB medium like in our previous 14 work, we readily reproduced the significant drop of ampicillin and ciprofloxacin survival that had been reported 15 for the Δ10TA mutants compared to E. coli K-12 wildtype (8, 9). Lysogenization of E. coli K-12 with ϕ80 had no 16 effect on ampicillin tolerance but caused the same drop of ciprofloxacin survival that had been a leading 17 phenotype of Δ10TA and other infected strains in our previous studies ( Figure 5D ; 8, 9). Furthermore, the 18 difference between E. coli K-12 wildtype and the Δ10TA mutants in ampicillin tolerance disappeared when the 19 experiment was performed in M9 minimal medium ( Figure 5E ), as had already been reported by Y. Shan, et al. 20
(5). Taken together, these results directly questioned whether there was any ϕ80-independent difference 21 between E. coli K-12 wildtype and the Δ10TA mutants in persister formation or survival. Interestingly, in M9 22 minimal medium the Δ10TA strains displayed clearly reduced survival of ciprofloxacin treatment when 23 compared to the ϕ80 lysogen, possibly due to some of the additional mutations present in the Δ10TA genome 24 revealed by Y. Shan, et al. (5) or due to the additional presence of ϕ80 h(80)imm (λ) . Unlike what we had observed 1 for the cryptic prophages of E. coli K-12 (Figure 3 ), an increase in the ciprofloxacin concentration from 2 commonly used 1 µg/ml to 10 µg/ml did not reduce the drop in survival caused by lysogenization with ϕ80 3 (Figures 5D and 5E ). It seems likely that this different behavior is due to the high sensitivity of ϕ80 induction to 4 even slight DNA damage that may remain after the end of ciprofloxacin treatment and persister resuscitation 5 (29), while the induction of cryptic prophages of E. coli K-12 requires very strong DNA damage (27) . No 6 differences between Δ10TA with and without the defective lambda prophage in the attB site or between any 7 strains regarding gentamicin tolerance could be detected ( Figures 5D and 5E ). 8 (p)ppGpp, Lon, and polyphosphate in E. coli K-12 persister formation
9
The ability of ϕ80 carriage to cause the same drop in persistence that we had previously attributed to 10 the deletion of ten TA modules was worrying, because we had found this prophage in nearly all mutant strains 11 that supported the model of persister formation proposed by our previous work (8). We therefore constructed 12 new, uninfected versions of all mutants that had been found to be ϕ80 lysogens and assayed the dynamics of 13 persister formation of these strains in order to determine whether the model still holds (see Figure 6A for a 14 summary of the model and Materials and Methods for strain construction). 15
This model is based on the second messenger (p)ppGpp that plays important roles in persister 16 formation of diverse organisms (2, 31). Consistently, we had previously reported severe defects in the 17 formation or survival of ampicillin-and ciprofloxacin-tolerant persisters for mutants deficient in (p)ppGpp 18 synthesis (relA spoT strains; (8)). Subsequently, there had been some debate in the field whether pleiotropic 19 phenotypes of these mutants like slow growth, long lag times, and reduced stationary phase viability might 20 have affected our results (5, 16). We therefore compared the dynamics of antibiotic tolerance in cultures of a 21 relA spoT mutant of E. coli K-12 MG1655 to the parental wildtype in a variant of our M9 medium that had been 22 supplemented with a mixture of amino acids to support growth at roughly the same rate for both strains (see 23
Materials and Methods as well as K. Potrykus, et al. (32) ). Under these conditions, we observed a considerable 24 defect of the relA spoT mutant in tolerance to ciprofloxacin and gentamicin throughout all growth phases, 1 though the overall shape of the curves following the levels of tolerant cells over time was only poorly affected 2 ( Figures 6B and 6C ). The relA spoT mutant also seemed to display a defect in tolerance to ampicillin during 3 exponential growth, though the very different final cell densities and the early onset of full ampicillin tolerance 4 upon cessation of growth by the relA spoT mutant made it difficult to judge this phenotype ( Figures 6B and 6C) . 5 Downstream of (p)ppGpp, the model proposed by E. Maisonneuve, et al. (8) comprises the production 6 of polyphosphate by PPK and degradation by PPX (both lacking in Δppkx that produces little polyphosphate), 7 the polyphosphate-dependent activation of Lon (impaired in a lon deletion), and the degradation of TA module 8
antitoxins by Lon to activate toxins and induce persistence (impaired in a Δ10TA knockout; Figure 6A ). Notably, 9 the only of these mutant strains of our previous studies that showed a defect in bacterial persistence but had 10 not been infected with ϕ80 was the lon::tet strain ( Figure 4D ; (8, 9)). However, the use of lon single mutants is 11 prone to artifacts in persister assays due to the activation of SulA, an inhibitor of cell division, in response to 12 DNA damage which is essentially irreversible in the absence of Lon that degrades SulA (26, 33). We therefore 13 created a sulA lon double mutant similar to the one that was used by A. Theodore, et al. (33) in order to 14 exclude these artifacts. This mutant showed a defect in the formation or survival of ciprofloxacin-tolerant 15 persisters during exponential growth and also exhibited a markedly slower increase in ampicillin tolerance 16 during stationary phase (Figure 7) . Conversely, the ppkx mutant showed a drop of ciprofloxacin tolerance only 17 in stationary phase and was, beyond a slightly shifted curve likely caused by its slower growth, not affected in 18 ampicillin tolerance (Figure 7 ). We therefore conclude that our results confirm roles of (p)ppGpp as well as the 19
Lon protease in the formation of persister cells by E. coli K-12, but these data cannot verify whether they are 20 part of the same pathway as suggested previously or not. Furthermore, we failed to detect any phenotype of a 21 newly constructed Δ10TA strain (called Δ10'TA) without prophages in tolerance to any of the tested antibiotics 22 at any time-point when compared to the parental wildtype strain (Figure 7 ). It appears therefore that 23 persister formation is generally well established (2, 31), recent studies suggested that the link between 16 (p)ppGpp signaling and the activation of TA modules needs to be reinvestigated. As an example, a dedicated 17 article by B. C. Ramisetty, et al. (18) and an associated commentary by L. Van Melderen and T. K. Wood (13) 18 raised the point that some of the antitoxins of the ten TA modules implicated in our model may not be targets 19 of the Lon protease. Furthermore, they used the yefM-yoeB TA module as a model to study the link between 20 (p)ppGpp and TA module activation and reported that polyphosphate was, in their hands, not required for 21
yefM-yoeB activation after experimental induction of (p)ppGpp signaling or Lon overexpression (18) . We agree 22 that the role of polyphosphate requires further investigation and, with the refined methodology of our current 23 study, we could not confirm a role of this molecule in the formation and survival of persister cells during 24 relatively high preference for lysogeny (29, 30). Contamination of strains with ϕ80 can therefore go unnoticed 19 for a long time -E. coli K-12 Δ5TA, the first strain of the TA module deletion series carrying ϕ80, was first 20 published by S. K. Christensen, et al. (41). However, elusive phenotypes such as a reduced efficiency of P1vir 21 transductions can be strong hints of ϕ80 contaminations (29). Due to the inability of ϕ80 to adsorb to 22 stationary phase cells, overnight cultures of lysogens regularly build up very high titers without any apparent 23 sign of lysis (see also Figure 5C ), facilitating contamination. Additionally, ϕ80 readily spreads through P1vir 24 transductions from infected strains (29). We can therefore only suggest our colleagues to take the danger of 1 ϕ80 contamination serious and use simple PCR tests like the one shown in Figure 4B to unravel if enigmatic 2 phenotypes may be caused by ϕ80 infection. Of note, we have tested a random sample of (published) E. coli 3 strains that we had obtained from different laboratories at different times and found several independent 4 cases of ϕ80 infection. 5
A refined methodology to study bacterial persister formation 6 Beyond the effects of ϕ80, we showed that the use of intermediate concentrations of fluoroquinolones 7 (like 0.5-1 µg/ml of ciprofloxacin) for persister assays with E. coli is inappropriate, because -in full congruency 8 with the results of E. L. Sandvik, et al. (25) for S. aureus -ca. one log of bacterial killing at these concentrations 9
is not directly caused by the antibiotic but rather by the induction of resident prophages (Figure 2 ). It can 10 therefore not be determined with certainty if phenotypes observed with experimental interventions or mutant 11 strains are caused by differences in persister formation / survival or by effects on prophage induction. Future 12 studies should therefore use higher concentrations of these antibiotics that inhibit prophage development, 13 e.g., 10 µg/ml of ciprofloxacin. 14 Our results further suggest that commonly used protocols to study "exponential phase" persister 15 designing experiments and possibly, e.g., include controls of bacteria that are in balanced growth, i.e., have 22 completed a sufficient amount of divisions since their inoculation from stationary phase so that effects of 23 carryover can be excluded (42). 24
In this study we regularly used a very laborious setup of antibiotic killing assays that followed the levels 1 of antibiotic-tolerant cfu/ml throughout the different growth phase of E. coli (see Figure 2A) . Similar 2 experiments have already been performed previously, e.g., in the seminal study by I. Keren, et al. (43) . Though 3 a number of experimental parameters differed between this study and our current work, there is clear 4 agreement that β-lactam and fluoroquinolone tolerance is similar in early growth phases after inoculation and 5 later increases strongly until it reaches (for β-lactams) full tolerance when bacteria cease growth ( Figures 1 and  6 2; compare the results of I. Keren, et al. (43)). It seems likely that the stable level of tolerant cells after 7 inoculation may reflect a long lag phase of dormant cells carried over from stationary phase, and others have 8 indeed found growth lag to be the most important aspect of antibiotic tolerance for bacteria that are 9 inoculated from stationary phase directly into fresh medium with antibiotics (44). It has therefore already been 10 reasonably argued in the field that future studies should follow sufficiently elaborate methodologies in order to 11 unravel the complexity of various antibiotic-tolerant subpopulations in bacterial cultures (16, 19, 21). We have 12 also observed very interesting and highly divergent dynamics of antibiotic tolerance of E. coli K-12 to different 13 antibiotics and in different media (Figures 1 and 2 ) that could not be explored in this study. However, it seems 14 a promising field for future studies to compare the appearance and disappearance of tolerant cells for different 15 antibiotics and try to uncover which external and intrinsic factors control antibiotic tolerance. 16 Spring Harbor Protocols (51) with modifications as 1x M9 salts (stock solution prepared from 5x M9 salts, 22
17

Materials and Methods
cat#M6030 Sigma-Aldrich, supplemented with 50 µl of a 10 mg/ml FeSO 4 solution (cat#F8048, Sigma)), 0.4% 23 ca. 16 hours in plastic culture tubes (cat#62.515.006, Sarstedt; lid arrested with tape at the 13-ml mark with its 18 lower end to ensure uniform aeration of replicates). For persister assays based on a single growth time-point as 19 described in Figure 1A , overnight cultures were diluted back 1:100 into LB or M9 medium in Erlenmeyer flasks 20 and agitated at 37°C in a waterbath shaker until they were in mid-exponential growth phase (ca. 1 -5 x 10 8 cfu 21 / ml; reached in our setup after ca. 2 -2.5 hours in LB medium or 2.5 -3 hours in M9 medium). At this point 22 cultures were treated with lethal concentrations of different antibiotics (100 µg/ml ampicillin, 1 or 10 µg/ml 23 acids (see above) and the experiment was extended to 10 hours. Though the relA spoT mutant and E. coli K-12 13 wildtype have roughly the same growth rate in this medium, the final cfu/ml of the (p)ppGpp-deficient mutant 14 is significantly lower which regularly results in experimental artifacts due to the appearance of suppressor 15 mutants during overnight cultures (32). We therefore set up overnight cultures in LB medium (where this effect 16 is much less pronounced) and adjusted the inoculum of both mutant and wildtype ad ca. 10 6 cfu/ml in order to 17 account for the roughly 3-fold higher cfu/ml of wildtype overnight cultures. by batch-to-batch variation of the LB medium (see Figure S1 ). n.d. = not detected (no gentamicin-tolerant 8 bacteria recovered at t = 0 h from inoculation 1:10000) 9 Changes in overall and antibiotic-tolerant cfu/ml are plotted in (A) and the fractions of antibiotic-tolerant cells are plotted in (B). While the sulA::FRT Δlon mutant shows a clear defect in persister formation or survival during exponential growth (around 3 hours after inoculation; see also Figure S2 ), the parental sulA::FRT strain had no phenotype ( Figure S3 ), confirming that the defect is due to the lack of Lon.
